OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+21.01%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$718M
AUM Growth
+$718M
(+7.9%)
Cap. Flow
-$28.2M
Cap. Flow
% of AUM
-3.93%
Top 10 Holdings %
Top 10 Hldgs %
87.69%
Holding
25
New
3
Increased
4
Reduced
12
Closed
–
Top Buys
| 1 |
Vir Biotechnology
VIR
|
$12.1M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
$10.3M |
| 3 |
Forian
FORA
|
$8.96M |
| 4 |
IMMP
Immutep
IMMP
|
$3.87M |
| 5 |
CDAK
Codiak BioSciences, Inc. Common Stock
CDAK
|
$2.47M |
Top Sells
| 1 |
QuidelOrtho
QDEL
|
$32.4M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$7.07M |
| 3 |
Select Medical
SEM
|
$5.77M |
| 4 |
AMRN
Amarin Corp
AMRN
|
$5.4M |
| 5 |
Capricor Therapeutics
CAPR
|
$4.27M |
Sector Composition
| 1 | Healthcare | 98.4% |
| 2 | Energy | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $202M | 27.86% | 2,082,555 -40,716 | -2% | -$3.95M |
|
|
2
QuidelOrtho
QDEL
$1.95B
| $107M | 14.78% | 837,109 -253,200 | -23% | -$32.4M |
|
3
Opko Health
OPK
$1.1B
| $51.9M | 7.16% | 12,819,073 -2,200 | -0% | -$8.91K |
|
|
AGEN
4
Agenus
AGEN
$133M
| $50.4M | 6.94% | 9,173,582 -200,000 | -2% | -$1.1M |
|
|
AWH
5
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $48.6M | 6.7% | 8,647,094 | – | – |
|
6
Pacific Biosciences
PACB
$393M
| $48.1M | 6.62% | 1,374,159 -72,300 | -5% | -$2.53M |
|
|
7
Vir Biotechnology
VIR
$686M
| $33.4M | 4.6% | 705,486 +255,155 | +57% | +$12.1M |
|
|
AXDX
8
DELISTED
Accelerate Diagnostics
AXDX
| $30.4M | 4.19% | 3,776,121 | – | – |
|
|
9
BioCryst Pharmaceuticals
BCRX
$1.74B
| $30.4M | 4.19% | 1,920,733 -446,937 | -19% | -$7.07M |
|
|
DMTK
10
DELISTED
DermTech, Inc. Common Stock
DMTK
| $27.3M | 3.76% | 655,877 -57,700 | -8% | -$2.4M |
|
|
CDAK
11
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $12.6M | 1.73% | 678,700 +133,340 | +24% | +$2.47M |
|
|
12
Forian
FORA
$61.3M
| $10.9M | 1.5% | 868,342 +712,902 | +459% | +$8.96M |
|
|
13
SPDR S&P Biotech ETF
XBI
$5.07B
| $10.3M | 1.42% | +76,200 | New | +$10.3M |
|
14
Y-mAbs Therapeutics
YMAB
$388M
| $10.2M | 1.4% | 300,642 -80,000 | -21% | -$2.7M |
|
|
ATRS
15
DELISTED
Antares Pharma, Inc.
ATRS
| $8.28M | 1.14% | 1,900,000 | – | – |
|
|
CFRX
16
DELISTED
ContraFect Corporation
CFRX
| $7.43M | 1.02% | 1,688,902 +136,479 | +9% | +$600K |
|
|
17
Capricor Therapeutics
CAPR
$287M
| $5.98M | 0.82% | 1,166,249 -833,215 | -42% | -$4.27M |
|
|
IMMP
18
Immutep
IMMP
$234M
| $3.87M | 0.53% | +1,000,000 | New | +$3.87M |
|
|
MOTS
19
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $3.85M | 0.53% | 3,697,551 -50,000 | -1% | -$52K |
|
|
20
Select Medical
SEM
$1.61B
| $3.74M | 0.52% | 88,589 -136,411 | -61% | -$5.77M |
|
|
AMRN
21
Amarin Corp
AMRN
$311M
| $3.73M | 0.51% | 851,335 -1,233,504 | -59% | -$5.4M |
|
22
Biodesix
BDSX
$62.6M
| $3.11M | 0.43% | 235,511 | – | – |
|
23
Soleno Therapeutics
SLNO
$3.6B
| $2.43M | 0.33% | 2,132,000 | – | – |
|
|
VTNR
24
DELISTED
Vertex Energy, Inc
VTNR
| $1.19M | 0.16% | +90,000 | New | +$1.19M |
|
25
Biogen
BIIB
$19.4B
| $835K | 0.12% | 2,412 | – | – |
|